Curebay Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
About Curebay Pharmacy
Curebay Pharmacy Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 December 2022 (Two years and one month 20 days old ). Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyadarshi Mohapatra, Vasant Nangia, and Shobhan Mahapatra serve as directors at the Company.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999OR2022PTC041420
-
Company No.
041420
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Dec 2022
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Curebay Pharmacy?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasant Nangia
|
Director | 05-May-2023 | Current |
|
Shobhan Mahapatra
|
Director | 12-Dec-2022 | Current |
|
Priyadarshi Mohapatra
|
Director | 12-Dec-2022 | Current |
Financial Performance of Curebay Pharmacy.
Curebay Pharmacy Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curebay Pharmacy?
In 2023, Curebay Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Curebay Technologies Private LimitedPriyadarshi Mohapatra and Shobhan Mahapatra are mutual person
-
Curebay Clinics Private Limited
Priyadarshi Mohapatra, Vasant Nangia and 1 more are mutual person
-
Helixotech Private LimitedPriyadarshi Mohapatra and Vasant Nangia are mutual person
-
Rizz Fragrances Private Limited
Vasant Nangia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Curebay Pharmacy?
Curebay Pharmacy has a workforce of 64 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curebay Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curebay Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
